KEGG   Equus przewalskii (Przewalski's horse): 103559205
Entry
103559205         CDS       T04644                                 
Symbol
BID
Name
(RefSeq) BH3-interacting domain death agonist
  KO
K04726  BH3 interacting domain death agonist
Organism
epz  Equus przewalskii (Przewalski's horse)
Pathway
epz01524  Platinum drug resistance
epz04071  Sphingolipid signaling pathway
epz04115  p53 signaling pathway
epz04210  Apoptosis
epz04215  Apoptosis - multiple species
epz04217  Necroptosis
epz04650  Natural killer cell mediated cytotoxicity
epz04932  Non-alcoholic fatty liver disease
epz05010  Alzheimer disease
epz05014  Amyotrophic lateral sclerosis
epz05022  Pathways of neurodegeneration - multiple diseases
epz05152  Tuberculosis
epz05160  Hepatitis C
epz05161  Hepatitis B
epz05162  Measles
epz05163  Human cytomegalovirus infection
epz05164  Influenza A
epz05167  Kaposi sarcoma-associated herpesvirus infection
epz05168  Herpes simplex virus 1 infection
epz05169  Epstein-Barr virus infection
epz05170  Human immunodeficiency virus 1 infection
epz05200  Pathways in cancer
epz05416  Viral myocarditis
epz05417  Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:epz00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04071 Sphingolipid signaling pathway
    103559205 (BID)
 09140 Cellular Processes
  09143 Cell growth and death
   04210 Apoptosis
    103559205 (BID)
   04215 Apoptosis - multiple species
    103559205 (BID)
   04217 Necroptosis
    103559205 (BID)
   04115 p53 signaling pathway
    103559205 (BID)
 09150 Organismal Systems
  09151 Immune system
   04650 Natural killer cell mediated cytotoxicity
    103559205 (BID)
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    103559205 (BID)
  09172 Infectious disease: viral
   05170 Human immunodeficiency virus 1 infection
    103559205 (BID)
   05161 Hepatitis B
    103559205 (BID)
   05160 Hepatitis C
    103559205 (BID)
   05164 Influenza A
    103559205 (BID)
   05162 Measles
    103559205 (BID)
   05168 Herpes simplex virus 1 infection
    103559205 (BID)
   05163 Human cytomegalovirus infection
    103559205 (BID)
   05167 Kaposi sarcoma-associated herpesvirus infection
    103559205 (BID)
   05169 Epstein-Barr virus infection
    103559205 (BID)
  09171 Infectious disease: bacterial
   05152 Tuberculosis
    103559205 (BID)
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    103559205 (BID)
   05014 Amyotrophic lateral sclerosis
    103559205 (BID)
   05022 Pathways of neurodegeneration - multiple diseases
    103559205 (BID)
  09166 Cardiovascular disease
   05417 Lipid and atherosclerosis
    103559205 (BID)
   05416 Viral myocarditis
    103559205 (BID)
  09167 Endocrine and metabolic disease
   04932 Non-alcoholic fatty liver disease
    103559205 (BID)
  09176 Drug resistance: antineoplastic
   01524 Platinum drug resistance
    103559205 (BID)
SSDB
Motif
Pfam: BID Bcl-2 NPHP3_N bcl-2I13
Other DBs
NCBI-GeneID: 103559205
NCBI-ProteinID: XP_070476438
LinkDB
Position
5:28555563..28584848
AA seq 194 aa
MDSKVSNGSGLQDEHITHLLVFSFLQNCSKRHFYKELEVLGHELPVQAYLWEDHDELQTD
GNRCSHFVARAEADSESQEEIIQHIARQLAQIGDRMDDSIHPRLVNNLAMQFMNVNLSEE
DRRQCLTSALEQVMQTYPKDMEKEKTMLMLSMLLAKKVANHTPSLLRDVFRTTVNFINQN
LLTYVRNLVRNEMD
NT seq 585 nt   +upstreamnt  +downstreamnt
atggattctaaggtcagcaatggttcaggcctccaggatgagcacatcacacacttgctg
gtgtttagcttcctccaaaactgctccaaacgtcatttctacaaagagctggaggtgttg
ggccatgaactgcccgtgcaagcttacctgtgggaggaccatgacgagctgcagacagat
ggcaaccggtgcagccacttcgtggcaagagcggaggcagattctgagagtcaagaggaa
ataatccagcatatcgccaggcaacttgcccaaataggggacaggatggacgacagcatc
cacccaaggctggtgaataacctggcaatgcagtttatgaatgtgaacctgtcggaggaa
gacagaagacagtgccttacttctgcgctggagcaggtcatgcagacttatcctaaagac
atggagaaggagaagaccatgctgatgttgtccatgctcttggccaaaaaggtggccaat
cacacaccgtctttgctccgtgacgtctttcgcacaacagtgaactttattaaccagaac
ctactcacctatgtgaggaacttagtcagaaatgagatggattga

DBGET integrated database retrieval system